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Abstract
The conventional calpains, m- and A-calpain, are suggested to be involved in apoptosis triggered by many different mechanisms.
However, it has not been possible to definitively associate calpain function with apoptosis, largely because of the incomplete selectivity of the
cell permeable calpain inhibitors used in previous studies. In the present study, Chinese hamster ovary (CHO) cell lines overexpressing A-
calpain or the highly specific calpain inhibitor protein, calpastatin, have been utilized to explore apoptosis signals that are influenced by
calpain content. This approach allows unambiguous alteration of calpain activity in cells. Serum depletion, treatment with the endoplasmic
reticulum (ER) calcium ATPase inhibitor thapsigargin, and treatment with calcium ionophore A23187 produced apoptosis in CHO cells,
which was increased in calpain overexpressing cells and decreased by induced expression of calpastatin. Inhibition of calpain activity
protected h-spectrin, but not a-spectrin, from proteolysis. The calpains seemed not to be involved in apoptosis triggered by a number of other
treatments. Calpain protected against TNF-a induced apoptosis. In contrast to previous studies, we found no evidence that calpains
proteolyze InB-a in TNF-a-stimulated cells. These studies indicate that the conventional calpains participate in some, but not all, apoptotic
signaling mechanisms. In most cases, they contributed to apoptosis, but in at least one case, they were protective. D 2002 Published by
Elsevier Science B.V.
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1. Introduction
Cell death can either be the consequence of a passive,
degenerative process, or the consequence of an active
process. The former type of cell death is termed necrosis,
the latter apoptosis, or programmed cell death (PCD).
Apoptosis was originally identified morphologically [1]. It
represents a mode of death that is actively driven by the cell.
Necrosis represents a passive consequence of gross injury to
the cell. It is morphologically distinct from apoptosis, and
its physiological consequences at the tissue, organ and
organism levels are also different.
Calpains are non-lysosomal cysteine proteases that are
present in the cells of many different eukaryotic single-
celled and multicellular organisms [2,3]. While there are a
number of members of the calpain gene family, the best
characterized have been named ‘‘conventional calpains’’: m-
and A-calpain, one or both of which is present in all
mammalian cells. The possible involvement of calpains in
apoptosis was first suggested in 1993 [4,5], and has been
reported for several cells including thymocytes, hippocam-
pal cells and hepatocytes [6–9]. Both a-spectrin and h-
spectrin breakdown by caspase-3 and calpain were reported
during apoptosis in neural cells [10,11]. The spectrin break-
down product (SBDP) SBDP120 of caspase-3 is a very
typical hallmark of apoptosis, on the other hand, calpain-
mediated SBDPs are generally found in necrotic as well as
in apoptotic neuronal death [12,13]. And the relative con-
tribution to SBDP from calpain is quite cell type specific
[14].
Although it is generally accepted that calpains are
involved in cell death processes, their exact role is
unknown, and little has been done to sort out their degree
of participation in any of the more common apoptotic
models. Moreover, the specificity of the calpain inhibitors
used for such experiments is crucial in interpreting results,
and to date, no satisfactorily selective calpain inhibitors
have been developed. Thus, there is still some confusion as
to the true targets of these tools vis-a`-vis apoptosis, and it is
difficult to rule out effects on proteasome and other intra-
cellular proteases.
In this study, CHO cell-derived clones were developed
that overexpressed either active A-calpain or calpastatin.
Unlike the synthetic calpain inhibitors, calpastatin specifi-
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cally inhibits activity of the conventional calpains in vivo.
By unambiguously increasing or decreasing calpain activity
in the cells, it has been possible to demonstrate a clear-cut
difference in participation of the conventional calpains in
the various apoptosis models in a single cell type: CHO
cells.
2. Materials and methods
2.1. Materials
SHI cells were selected from a CHO cell line by chal-
lenging with the calpain inhibitor, ZLLY-DMK, as previ-
ously described [15]. They possess one-third to one-half of
the A-calpain content of the parental CHO cells. Thapsigar-
gin, A23187, staurosporine, H2O2, EGTA and (3-[4,5-yl]-
2,5-diphenyltetrazolium bromide) (MTT) were obtained
from Sigma. EcR-CHO cells, ponasterone A, zeocin, and
the pIND (SP1)/V5-His C vector for ecdysone-inducible
expression from EcR-CHO cells were purchased from
Invitrogen. The calpain small subunit cDNAwas a gift from
Dr. John S. Elce at Queen’s University, Kingston, Ontario,
Canada. The full-length human calpastatin cDNAwas a gift
from Dr. Masatoshi Maki, Nagoya University, Japan. Pro-
teinase K, Rnase A were purchased from Promega. Mouse
anti-spectrin (nonerythroid) monoclonal antibody was
obtained from Chemicon. Mouse anti-h-spectrin monoclo-
nal antibody and the calpain inhibitor SJA6017 were gifts
from Dr. Kevin K.W. Wang at Pfizer, Ann Arbor Laborato-
ries, USA. Anti-mouse IgG, biotinylated species-specific
whole antibody (from sheep), and streptavidin-alkaline
phosphatase were purchased from Amersham Pharmacia
Biotech. InB-a polyclonal antibody was obtained from
Santa Cruz. Mouse anti-human A-calpain large subunit
monoclonal antibody, 1A-11; mouse anti-human calpastatin
monoclonal antibody 5-8A; mouse anti-calpain small sub-
unit monoclonal antibody, P-1; and a rabbit immune serum
against bovine m-calpain, which also recognized the hamster
antigen, were made in-house. Fibroblasts derived from
calpain small subunit knockout [Capn4 ( / )] mouse
embryos, or from wild-type littermates [16], were kindly
provided by Dr. John S. Elce.
2.2. Human calpain overexpressing clones
Human A-Calpain large subunit cDNA, and rat p21
truncated calpain small subunit cDNA [17], were separately
inserted into pSBC-B and pSBC-A plasmids, respectively.
These plasmids were cut and ligated as previously described
[18], to form a dicistronic construct, pSBC-S/L, having the
calpain small subunit upstream of the large subunit, and
separated by an internal ribosomal entry sequence. SHI cells
were co-transfected with pSBC-S/L and NEO vectors, and
G418 was used for selection. A4 cells were derived by
transfection with pSBC-B containing A-calpain large sub-
unit alone. However, a heterodimeric A-calpain appeared to
be expressed in A4 clone, because the human A-calpain
immunoreactivity could be co-immunoprecipitated from A4
cell lysates using P-1 small subunit antibody (not shown).
Several human calpain producing cell lines were estab-
lished, and the two that expressed high levels of active
human A-calpain, SL18 and SL225, were chosen for this
study. Twenty cell lines with no detectable human A-calpain
expression by Western blot were pooled together randomly,
and early passages of this cell pool were used as mock-
transfected cells, SHI-NEO.
2.3. Human full-length calpastatin overexpressing clones
The full-length human calpastatin cDNA was inserted
into the polylinker EcoRI site of pIND (SP1)/V5-His C
vector. EcR-CHO cells, which already constitutively express
ecdysone receptor, were transfected with the calpastatin
construct using electroporation, and selected in the presence
of G418 (1.4 mg/ml) and zeocin (0.25 mg/ml). We identified
two stable cell lines, clone 83 and 106, which overexpressed
human calpastatin when induced with ponasterone. Clone
83 was chosen for most of our studies, because its morpho-
logic and growth characteristics were very similar to the
parental EcR-CHO cells. Clone 106 displayed a slightly
larger size and elongated appearance. Mock-transfected
cells, which did not express the human calpastatin, were
obtained by transfecting the EcR-CHO cells with empty
pIND (SP1)/V5-His C vector.
2.4. Protease and inhibitor assays
Calpain activity was determined by measuring the release
of trichloroacetic acid (TCA)-soluble fragments from 14C-
methylcasein [19]. CHO cells or clones were lysed in a
hypotonic buffer: 50 mM imidazole–HCl, 1 mM EGTA, 1
mM dithiothreitol, 70 mM NaCl, pH 7.4. Under these
conditions, calpains are extracted, but much of the calpas-
tatin remains sedimentable [20, unpublished observations];
allowing assay of calpain activity in 10,000 g super-
natants of the lysate. Calpastatin activity was determined
by its ability to inhibit a defined amount of purified human
erythrocyte A-calpain (1 ng/Al) in the standard 14C-casein-
olytic assay. The inhibition activity was calculated by
subtracting the percentage of calpain activity remaining
from 100%. Proteasome was assayed fluorometrically, using
Succinyl-LLVY-MCA as the substrate, as previously
described [21].
2.5. Cell culture and treatments
SL clone cells were cultured in 5% CO2 and 95%
humidified air atmosphere at 37 jC in complete IMDM
medium supplemented with heat-inactivated 10% bovine
serum, 100 units/ml penicillin, and 100 Ag/ml streptomycin.
Calpastatin overexpressing clones were cultured in complete
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Ham’s F12 medium containing 10% heat-inactivated fetal
bovine serum and the same antibiotics. For induction of
calpastatin expression, clone 83 cells were cultured until
95–100% confluent, and pre-treated for 3 days with 5 AM
ponasterone A before any other treatments. Mock-trans-
fected EcR-CHO cells were subjected to the same pre-
treatment protocol. Cells were either further treated with
100 nM thapsigargin for 3 days, 5 AM A23187 for 2 days, 1
AM staurosporine for 24 h, 3 mM EGTA for 24 h, or 3–10
mM H2O2 in serum-free medium for 2 h, then changed back
to normal medium for another 24 h before harvest.
2.6. MTT assay
Cell viability was estimated by using the MTT assay
method [22]. Cells were cultured in 96-well plates until 90–
100% confluent, and treated by different cell death stimuli
for various durations. Adding 0.5 mM MTT to the plates,
followed by incubation at 37 jC for at least 4 h. Isopropa-
nol—0.1 N HCl, 100 Al, was added to dissolve the reduced
tetrazolium dye. OD595 was determined using the Softmax
software provided with a Thermomax microplate reader
from Molecular Device Corp. For serum deprivation experi-
ments, cells were cultured in the absence of serum for 24 h
before assay. UV light irradiation experiments were per-
formed as described [23]. Briefly, culture medium was
exchanged for a PBS/Mg2 + solution, and the cells were
exposed to 254 nm radiation at 5 mJ/cm2 for different times.
They were then changed back to the usual growth medium,
and further cultured for another 2 days before performing
MTT assays. Irradiation was carried out by using the
Stratagene product StratalinkerR UV cross-linker.
2.7. Extraction of proteins, immunoblots, and densitometric
analysis
Cells were cultured in 12-well plates until about 100%
confluent, and treated by different stimuli at different con-
centrations for different times as described in Section 2.5.
Cells were collected, washed with ice-cold PBS, and lysed in
the cell lysis buffer (1% Triton X-100, 20 mM Tris, 150 mM
NaCl, 5 mM EDTA, 5 mM EGTA, 100 AM Na3VO4, 100
Fig. 1. Characterization of CHO cell clones that overexpress A-calpain. SHI clone of CHO cells was transfected with a dicistronic vector containing human
A-calpain large subunit and rat small subunit cDNAs, as described in Materials and methods. Clone A4 was transfected with A-calpain large subunit alone, as
described in Materials and methods. Cell lysates were assayed for calpain activity at 200 AM Ca2 + , to specifically detect the A-calpain isozyme (panel A).
Other samples were subjected to protein immunoblot analysis for heterologously expressed human A-calpain large subunit (panel B). Hamster m-calpain
large subunit (panel C), and calpastatin (panel D) were detected using antibodies with broad species specificities. Duplicate lanes for each cell line were
loaded in panels B through D.
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nMmicrocystin-LR, 200 AM phenylmethylsulfonyl fluoride,
10 AM pepstatin A, and 1 mM dithiothreitol, pH 7.4) on ice
for 10 min, then homogenized for about eight strokes, and
centrifuged at 4 jC, 10,000 g for 10 min. Quantitation of
supernatant protein was carried out with the BCA reagent
[24]. Supernatants were treated with SDS-PAGE sample
buffer, and equal amounts of sample protein were subjected
to 7.5% polyacrylamide SDS-PAGE. The gels were subse-
quently transferred to polyvinylidene difluoride membranes
by electroblotting at 4 jC for 3 h at 70 V. Immunoblotting
was performed with the following first antibodies: mouse
anti-spectrin (nonerythroid) monoclonal antibody (1:2000);
mouse anti-h-spectrin monoclonal antibody (1:700); rabbit
Fig. 3. Calpastatin overexpression inhibited calpain autoproteolysis. Clone
83 cells or mock-transfected EcR-CHO cells were cultured for 3 days with
our without 5 AM ponasterone A in the culture medium. Where indicated,
100 nM thapsigargin or 3 AM A23187 were then added to the medium.
After 2 more days in culture (A23187) or 3 more days (thapsigargin), cell
lysates were prepared and subjected to protein immunoblot analysis for
calpain small subunit.
Fig. 2. Regulated expression of human calpastatin in clone 83 CHO cells.
Clone 83 cells stably transfected with pIND vector expressing human full-
length calpastatin were cultured minus or plus 5 AM ponasterone A for 3
days. Cell lysates were subjected to protein immunoblot analysis using a
human-specific calpastatin antibody (panel A), or heat-treated as described
in Materials and methods and assayed for calpastatin activity (panel B).
Fig. 4. Calpastatin overexpression increased viability of clone 83 cells
exposed to thapsigargin or A23187. Clone 83 cells were cultured plus (filled
bars) or minus ponasterone, and then exposed to 100 nM thapsigargin (panel
A) or 3 AM A23187 (panel B). After 1, 2 or 3 days, cell survival was
measured by MTT reductase activity as described in Materials and methods.
Where indicated, values were significantly different from the minus
ponasterone sample at the same time point; * =P< 0.01, ** =P < 0.001.
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anti-m-calpain large subunit (1:1000); mouse anti-calpain
small subunit monoclonal antibody, P-1, (2 Ag/ml); mouse
anti-human A-calpain large subunit monoclonal antibody,
1A-11 (2 Ag/ml); mouse anti-human calpastatin monoclonal
antibody 5-8A (2 Ag/ml). Immunodetection was carried out
with alkaline phosphatase second antibody, and BCIP sub-
strate with nitro-blue tetrazolium development [25]. Densi-
tometry was performed with a Bio-Rad bioscanner and
Molecular Analyst software.
2.8. Cell morphology
Cells were cultured until about 100% confluence, and
treated by the indicated stimuli for the indicated times as
described in Section 2.5. Phase-contrast photomicrographs
were taken using a Nikon N 5005 inverted phase-contrast
microscope and camera at 100 magnification.
2.9. DNA fragmentation assay
Cells were cultured in 60 mm petri dishes, and treated by
different stimuli at the indicated conditions. Cells were lysed
in 500 Al of DNA extraction solution (50 mM Tris–HCl, 10
mM EDTA, 0.5% Triton, and 100 Ag/ml proteinase K, pH
8.0). After incubating overnight, Dnase-free Rnase A was
added to 100 Ag/ml. The samples were incubated at 37 jC
for 2 h, extracted with an equal volume of phenol/chloro-
form (1:1 v/v), and centrifuged at 20,000 g for 10 min at
4 jC. The aqueous phase was re-extracted with chloroform.
DNAwas collected by precipitating the aqueous supernatant
Fig. 5. Calpastatin overexpression attenuated cell rounding associated with thapsigargin and A23187-induced cell death. Clone 83 and mock-transfected cells
were treated with 100 nM thapsigargin or 3 AM A23187 as described in Materials and methods, then observed by phase contrast microscopy at 100
magnification.
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with 2 volumes of cold absolute ethanol in the presence of
1/10 volume of 3 M NaAc. After washing with 70%
ethanol, the DNA pellet was dissolved in 40 Al of 10 mM
Tris–HCl and 1 mM EDTA, pH 8.0. DNAwas separated on
1.8% agarose gel containing 0.5 Ag/ml ethidium bromide,
and DNA fragments were visualized by exposing the gels to
UV light.
2.10. Statistical analysis
Where indicated, samples were analysed by Students
unpaired t-test. Results are expressed as meanF standard
deviation.
3. Results
3.1. Characterization of clones overexpressing calpain or
calpastatin
Calpain overexpressing clones were established by co-
transfecting Neo vector and the pSBC-S/L construct, which
had both the A-calpain large subunit and calpain small
subunit, into SHI cells. Seven cell lines expressing human
A-calpain were established (Fig. 1). S/L18 and S/L225 cells
were chosen for further study, because they expressed
intermediate and high levels of A-calpain, respectively
(Fig. 1A). Moreover, they displayed morphologies and
growth characteristics comparable to the mock-transfected
Fig. 6. Calpastatin overexpression decreased DNA ladder formation in
A23187 and thapsigargin-treated cells. Clone 83 and mock-transfected cells
were exposed to thapsigargin or A23187 as described in Materials and
methods. DNA was prepared and subjected to electrophoretic analysis for
fragmentation as described in Materials and methods.
Fig. 7. Calpastatin overexpression inhibited h-spectrin proteolysis in
thapsigargin-treated cells. Clone 83 and mock-transfected cells were treated
with thapsigargin as described in Materials and methods. Cell lysates were
subjected to SDS-PAGE and protein immunoblotting using anti-a-spectrin
antibody (panel A) or anti-h-spectrin antibody (panel B), as described in
Materials and methods. The asterisk in panel A shows the location of the
immunoreactive band at slightly higher mobility than a-spectrin that was
consistently protected by calpastatin overexpression.
Table 1
Effect of calpastatin overexpression on loss of h-spectrin following
exposure to thapsigargin or A23187
Drug Cells Ponasterone Degradation of
h-spectrinF SD
relative to untreated
samples (%)
Thapsigargin mock  72F 1
mock + 70F 5
clone 83  74F 1
clone 83 + 42F 6*
A23187 mock  65F 10
mock + 67F 11
clone 83  76F 8
clone 83 + 62F 7**
* P< 0.01 vs. minus ponasterone sample.
** P< 0.05 vs. minus ponasterone sample.
T. Lu et al. / Biochimica et Biophysica Acta 1590 (2002) 16–26 21
(SHI-NEO) cells. In contrast, S/L115 cells, which expressed
between 3 and 4 units of A-calpain/mg protein (Fig. 1A),
displayed an elongated cell shape, and a slower growth rate
than the other clones (data not shown). All clones expressed
comparable levels of m-calpain (Fig. 1C) and calpastatin
(Fig. 1D).
EcR-CHO cells were transfected with the full-length
calpastatin construct pIND (SP1)/V5-His C vector and
selected in the presence of G418 (1.4 mg/ml) and Zeocin
(0.25 mg/ml) antibiotics. Clone 83 derived from these
studies stably expressed human calpastatin when exposed
to micromolar ponasterone A in the culture medium (Fig.
2A). Direct assay of calpastatin activity in clone 83 lysate
demonstrated a 2- to 3-fold increase in calpastatin activity
upon induction with ponasterone A (Fig. 2B).
To determine whether expressed human calpastatin
could inhibit calpains in intact cells, clone 83 cells were
cultured in the presence of A23187 or thapsigargin, both
of which activated calpains, as evidenced by increased
autoproteolysis of calpain small subunit (Fig. 3; lanes 1, 2,
5, and 6). Overexpression of calpastatin decreased autopro-
teolysis (Fig. 3; lanes 3, 4, 7, and 8). No protection was
observed when mock-transfected cells were exposed to
ponasterone A.
3.2. Effect of altering calpain or calpastatin content on
survival of cells exposed to A23187- or thapsigargin-
induced apoptosis
Initial studies of the effect of calpain content on cell
survival were carried out utilizing the calpastatin-overex-
pressing clone 83. The divalent cation ionophore A23187,
and thapsigargin, an inhibitor of the endoplasmic reticulum
calcium pump, were used as apoptogenic agents. As pre-
viously noted, both of these reagents activate calpains in
CHO cells (Fig. 3). Treatment with either A23187 or
thapsigargin resulted in time-dependent cell death, which
was inhibited by calpastatin overexpression (Fig. 4). Light
microscopic examination of cells exposed to A23187 or
thapsigargin confirmed that calpastatin overexpression
inhibited cell damage, as evidenced by decreased rounding
and lifting from the culture surface (Fig. 5). No protection of
apoptosis was observed in mock-transfected cells treated
with ponasterone (Fig. 5; top).
The MTT reductase assay utilized to measure cell sur-
vival cannot distinguish between apoptosis and necrosis.
Therefore, further studies were carried out to confirm that
A23187 and thapsigargin trigger apoptosis in the cell lines
utilized in the present investigation. Both treatments pro-
duced DNA fragmentation into a multi-nucleosomal ‘‘DNA
ladder’’ (Fig. 6), typical of apoptosis. Overexpression of
calpastatin attenuated DNA breakdown (Fig. 6; panel B).
Spectrin proteolysis has been utilized as a marker for
apoptosis, especially generation of the 120 kDa a-spectrin
fragment by caspase 3 [26]. Exposure of clone 83 cells to
either thapsigargin or A23187 resulted in a substantial
Fig. 8. Clone 83 cells exposed to H2O2 undergo necrotic cell death. Clone 83
cells were cultured in the presence of H2O2 as described in Materials and
methods. Panel A DNA was isolated and electrophoresed to detect frag-
mentation. Panel B shows the H2O2 concentration dependence of spectrin
degradation.
Table 2
The effects of different stimuli on the cell death of calpastatin overexpressing clone #83 and calpain overexpressing S/L clones
Percent cell survival
Calpastatin overexpressing Calpain overexpressing
Mock Clone 83 Mock S/L18 S/L225
 Ponasterone + Ponasterone  Ponasterone + Ponasterone
Treatment
 Serum 62.1F 2.5 58.3F 3.7 60.0F 3.1 78.1F 5.4 * 53.1F1.4 50.7F 2.1 29.4F 1.8#
A23187 26.6F 1.4 25.0F 0.8 23.6F 1.5 37.9F 2.4 * 51.9F 1.4 50.8F 2.5 41.3F 0.7#
Thapsigargin 66.2F 2.4 68.0F 2.4 65.0F 2.6 86.9F 3.3 * 49.9F 2.0 42.0F 0.8# 40.6F 1.1#
Staurosporine 35.7F 4.4 37.0F 1.3 35.3F 6.8 39.9F 1.5 36.2F 1.1 34.2F 1.0 37.0F 0.3
EGTA 66.0F 1.7 65.4F 1.4 68.0F 1.6 66.8F 2.5 64.2F 1.7 65.5F 0.8 64.6F 1.7
H2O2 30.3F 6.7 29.9F 4.4 31.3F 3.3 30.2F 4.0 47.4F 1.5 47.1F 3.3 43.7F 1.7
UV 54.7F 2.7 53.6F 2.0 56.1F 2.6 53.1F 2.3 46.6F 0.6 44.7F 0.9 45.4F 2.0
*P< 0.001 compared with  ponasterone samples.
# P < 0.001 compared with mock-transfected cells.
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increase in spectrin immunoreactivity at 120 kDa on protein
blots (Fig. 7; panel A). However, increased expression of
calpastatin had no apparent effect on generation of the 120
kDa fragment. In contrast, a minor immunoreactive band
slightly smaller than a-spectrin was consistently spared
(Fig. 7; panel A, asterisk). Utilization of a selective antibody
demonstrated that this band was h-spectrin, and that its
proteolysis was reduced upon calpastatin overexpression
(Fig. 7; panel B). Overexpression of calpastatin in clone
83 cells resulted in a significant reduction of h-spectrin
proteolysis induced by thapsigargin or A23187 treatment,
under the conditions of our studies (Table 1).
3.3. Contribution of the conventional calpains to cell death
produced by other apoptotic models
The availability of CHO cells overexpressing A-calpain
or calpastatin allowed a systematic survey of calpain
involvement in other commonly studied apoptotic models
(Table 2). The MTT reductase assay demonstrated that cell
death produced upon serum withdrawal appeared to have a
calpain component, as evidenced by its exacerbation by
calpain overexpression, and the protective effect of calpas-
tatin overexpression. Of the other apoptotic triggers studied,
none except A23187 and thapsigargin appeared to be
influenced by calpain/calpastatin balance. Further experi-
ments were carried out to determine the mechanism of cell
death in these studies. DNA fragmentation and spectrin
proteolysis analysis confirmed that the conditions in Table
Fig. 9. Calpain overexpression protects against TNF-a-induced apoptosis of
SHI cells. Clones S/L18, S/L225 and mock-transfected SHI cells (Neo)
were cultured in the presence of TNF-a for 20 h. Panel A: cell survival was
determined by MTT reductase assay as described in Materials and methods.
Panel B: DNA was prepared and analyzed for fragmentation.
Fig. 10. Apoptosis of calpain small subunit knockout mouse fibroblasts.
Fibroblasts isolated from Capn4 ( / ) mouse embryos or a Capn4 (+/+)
littermate were subjected to several of the apoptotic signals previously
utilized in experiments with the calpain and calpastatin overexpressing
CHO cell lines. Survival was determined by the MTT reductase assay, as
described in Materials and methods. N= 8 for each bar; * =P< 0.01 vs.
Capn4 (+/+), ** =P< 0.05 vs. Capn4 (+/+).
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2, except exposure to H2O2, resulted in apoptosis (data not
shown). H2O2 produced necrotic cell death at all concen-
trations studied (Fig. 8), with accompanying non-distinct
DNA fragmentation, and proteolysis of a-spectrin without
production of the distinct 120 kDa fragment.
3.4. Calpain protected against TNF-a triggered apoptosis
In contrast with the results presented in Table 2, calpain
overexpression was found to protect against cell death
signaling by TNF-a (Fig. 9A). Assessment of DNA ladder
formation demonstrated apoptosis as the mechanism for
cell death, and confirmed the protective effect of calpain
overexpression (Fig. 9B). To assess the generality of
calpain protection against TNF-a-stimulated apoptosis,
fibroblasts derived from calpain small subunit knockout
[Capn4 ( / )] mouse embryos were utilized. Compared
with wild-type mouse fibroblasts, the Capn4 ( / ) fibro-
blasts were more sensitive to TNF-a induced apoptosis
(Fig. 10). In contrast, the knockout fibroblasts were less
sensitive to apoptosis produced by addition of A23187 to
the culture medium, or serum deprivation.
Previous studies in isolated hepatocytes have indicated
that calpains can proteolyze InB-a, thereby releasing NF-
nB [27]. This is consistent with a protective effect of
calpain in apoptosis, because it would allow expression of
anti-apoptotic genes by NF-nB. However, in the present
investigation, there was no detectable change in InB-a
stability in the calpain overexpressing cell lines (data not
shown). To further investigate calpain participation in InB-
a degradation, the effects of lactacystin and SJA6017 were
explored. The former is a selective proteasome inhibitor
[28,29], while the latter is a potent calpain inhibitor having
no detectable inhibitory activity on proteasome (Fig. 11A).
InB-a degradation in response to TNF-a was nearly com-
pletely abolished by lactacystin pre-treatment (Fig. 11B),
while SJA6017 did not noticeably protect InB-a (Fig. 11C).
Therefore, the protective influence of calpain did not appear
to be related to InB-a proteolysis.
4. Discussion
By manipulating expression levels of A-calpain and
calpastatin, it has been possible to alter the sensitivity of
CHO cells to apoptotic stimuli. These results indicate that
the conventional calpains (A- and m-calpain), which are
inhibited by calpastatin, participate in some apoptotic
pathways. Preliminary studies with calpain small subunit
knockout mouse fibroblasts confirm this observation (Fig.
10). Notably, of the different systems studied, only apop-
tosis associated with A23187, thapsigargin, or serum
depletion was shown to be increased by a positive cal-
pain/calpastatin balance (Table 2). Cell death following
exposure of CHO cells to staurosporine, EGTA, or ultra-
violet light was not detectably influenced by calpain con-
tent. Calpain did not influence cell death upon exposure to
H2O2. In some cell types, H2O2 produces apoptotic cell
death [30–32]. However, it only produced necrotic death
of CHO cells over a range of concentrations. Therefore,
the influence of calpain on apoptosis produced by H2O2
could not be addressed by the present studies. Other well-
characterized apoptotic stimuli could not be studied in the
CHO cell system, because significant cell death was not
observed. For example, silica fibers, which produce apop-
tosis in some cells [33,34], simply did not kill the CHO
cells (data not shown).
Calpain protected against apoptosis produced by TNF-a.
Other investigators have found that calpain can cleave
InB-a in hepatocytes stimulated with TNF-a [27]. In
principle, this would lead to increased levels of free NF-
nB transcription factor, which could translocate to the
nucleus and increase expression of anti-apoptosis genes.
Fig. 11. Calpains do not appear to proteolyze InB-a after exposure of CHO
cells to TNF-a. Panel A: SJA6017 was assayed for inhibitory activity
against purified human m-calpain (filled circles) or human proteasome
(hollow circles). In other studies, the effect of various concentrations of
lactacystin (panel B) or SJA6017 (panel C) on degradation of InB-a was
explored utilizing protein immunoblot experiments and anti-InB-a anti-
body.
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However, InB-a did not appear to be a calpain target in the
CHO cells used in the present studies. Very recently, it has
been reported that TNF-a-dependent NF-nB activation in
dermal fibroblasts is TRAF2- and NIK-independent, but
requires sphinomyelinase and calpain activity [35]. Thus,
calpain appears to act through a mechanism separate from
the NIK:InB-a phosphorylation pathway. Further investiga-
tion will be required to elucidate the mechanism by which
calpains protect against TNF-a-stimulated apoptosis.
A further surprising result from the present studies was
the apparent lack of effect of calpain on a-spectrin proteol-
ysis. Although calpastatin overexpression partially protected
against apoptosis secondary to A23187 or thapsigargin
treatment, a-spectrin was not noticeably protected from
proteolysis (Fig. 7). Furthermore, the predominant break-
down product was the 120 kDa band expected from caspase
cleavage of a-spectrin [26], suggesting that caspases are
responsible for the majority of a-spectrin breakdown in
these studies. Interestingly, there was significant protection
of h-spectrin proteolysis upon calpastatin overexpression
(Fig. 7B and Table 1). Although calpainolysis of a-spectrin
has been most extensively studied, both a- and h-spectrins
have been shown to be calpain substrates [36,37], and
cleavage of both is required to fully dismantle the cortical
cytoskeleton [11]. It was previously shown that in eryth-
rocytes, only h-spectrin is cleaved by calpains [38]. If
a-spectrin is predominantly proteolyzed by caspases in
some cell types, while calpains degrade h-spectrin, this
would provide a rational framework for utilizing combina-
tions of caspase and calpain inhibitors to inhibit apoptotic
death in these cell types.
In conclusion, the present studies demonstrate that direct
alteration of the calpain/calpastatin balance in CHO cells
influences some apoptotic systems, but not others. In no
case did abrogation of conventional calpain activity lead to
complete protection against apoptosis. Therefore, these
calpains do not appear to be indispensable for this process.
For a complex function like programmed death, it would be
surprising if compromising one part of the signaling system
would completely abolish the overall event. It is important
to note that the changes in calpain and calpastatin expres-
sion levels displayed by the CHO cell clones described in
this study are within the physiologic range observed in
various cell types. For example, the amount of A-calpain in
the S/L 225 clone is similar to the level measured in blood
platelets [39], and the maximum content of calpastatin in
clone 83 cells after 3 or more days of induction with
ponasterone A is only 2 or 3-times the level of endogenous
hamster calpastatin (Fig. 2). Some of the apoptotic proto-
cols utilized in these studies were clearly pharmacological
in nature. However, two of the calpain-responsive apoptotic
stimuli, TNF-a treatment, and abrogation of the serum
survival pathway, represent physiologic apoptotic path-
ways. It will be important to determine which signal trans-
duction events in these latter pathways are influenced by
calpains.
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